We are live on ! Find out more
PRGO icon

Perrigo

15.78 USD
-0.12
0.75%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
15.71
-0.07
0.44%
1 day
-0.75%
5 days
-1.68%
1 month
6.91%
3 months
53.06%
6 months
33.28%
Year to date
13.61%
1 year
-23.55%
5 years
-65.94%
10 years
-81.03%
 

About: Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Employees: 8,100

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 65%
Neutral 30%
Negative 5%
Neutral
PRNewsWire
3 days ago
Perrigo Announces Quarterly Dividend
DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on December 15, 2026, to shareholders of record on November 27, 2026.
Perrigo Announces Quarterly Dividend
Neutral
PRNewsWire
3 days ago
Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplification Furthers Perrigo's evolution into a simpler, more focused consumer self-care company Expected to enhance Perrigo's margin profile and eliminate significant expected future capital expenditures Aligns reported results more closely with the financial profile of Core Perrigo MeridianMade's infant-grade, American manufacturing infrastructure and operating capabilities will support the continued supply of safe, high-quality, and affordable infant nutrition DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company"), a leading provider of consumer self-care products, today announced that it has entered into a definitive agreement pursuant to which MeridianMade, an American contract manufacturing platform dedicated to infant nutrition, will acquire Perrigo's Infant Formula business for total consideration of up to $175 million. The transaction consists of $40 million in cash at closing and up to an additional $135 million contingent on the achievement of future performance milestones through 2030.
Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
Negative
Zacks Investment Research
4 days ago
Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline
Neutral
PRNewsWire
11 days ago
Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026
DUBLIN, Oct. 21, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its third quarter 2026 financial results on Wednesday, November 4, 2026. The company will hold a conference call beginning at 8:30 a.m.
Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026
Positive
Zacks Investment Research
1 month ago
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Positive
Zacks Investment Research
1 month ago
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?
Neutral
PRNewsWire
2 months ago
Perrigo to Attend the Barclays Global Consumer Conference
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026.  About Perrigo    Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.
Perrigo to Attend the Barclays Global Consumer Conference
Positive
Zacks Investment Research
2 months ago
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
2 months ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Perrigo (PRGO) Stock?
Positive
Benzinga
2 months ago
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Price charts implemented using Lightweight Charts™